Bio-Rad Laboratories (BIO-B) Gross Profit Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.03% |
| Dec 31, 2025 | -5.58% |
| Sep 30, 2025 | -1.34% |
| Jun 30, 2025 | 3.34% |
| Mar 31, 2025 | -0.73% |
| Dec 31, 2024 | 0.69% |
| Sep 30, 2024 | 3.00% |
| Jun 30, 2024 | 2.90% |
| Mar 31, 2024 | 0.89% |
| Dec 31, 2023 | 1.95% |
| Sep 30, 2023 | 3.21% |
| Jun 30, 2023 | 3.74% |
| Mar 31, 2023 | 3.70% |
| Dec 31, 2022 | 2.84% |
| Sep 30, 2022 | 4.50% |
| Jun 30, 2022 | 7.64% |
| Mar 31, 2022 | 8.31% |
| Dec 31, 2021 | 4.93% |
| Sep 30, 2021 | 9.33% |
| Jun 30, 2021 | 7.44% |
| Mar 31, 2021 | 8.69% |
| Dec 31, 2020 | 8.32% |
| Sep 30, 2020 | 6.87% |
| Jun 30, 2020 | 0.94% |
| Mar 31, 2020 | 3.28% |
| Dec 31, 2019 | 0.81% |
| Sep 30, 2019 | 1.24% |
| Jun 30, 2019 | 0.70% |
| Mar 31, 2019 | 2.52% |
| Dec 31, 2018 | 0.61% |
| Sep 30, 2018 | 0.18% |
| Jun 30, 2018 | 0.11% |
| Mar 31, 2018 | 2.17% |
| Dec 31, 2017 | 1.91% |
| Sep 30, 2017 | 1.78% |
| Jun 30, 2017 | -1.03% |
| Mar 31, 2017 | -0.62% |
| Dec 31, 2016 | 0.22% |
| Sep 30, 2016 | -1.15% |
| Jun 30, 2016 | -0.90% |
| Mar 31, 2016 | -1.00% |
| Dec 31, 2015 | 0.58% |
| Sep 30, 2015 | -0.21% |
| Jun 30, 2015 | 0.83% |
| Mar 31, 2015 | 0.99% |
| Dec 31, 2014 | 3.41% |
| Sep 30, 2014 | 2.07% |
| Jun 30, 2014 | 4.20% |